ArticleJournal of nanobiotechnology2022

Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment.

Tianze Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.